The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Elliott John Raymond since 2007.
The trader's CIK number is 1238656.
At the time of the last reporting, Elliott John Raymond was the Chairman, Pres. & CE of Boston Scientific Corp. (stock ticker symbol BSX).
Also see all insider trading activities at Boston Scientific Corp.
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2007 | ZMH | 0 | $0 | 360,618 | $30,328,613 | 360,618 | $10,771,661 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2011 | BSX | 0 | $0 | 0 | $0 | 333,333 | $0 |
2010 | BSX | 0 | $0 | 0 | $0 | 500,000 | $0 |
2009 | BSX | 100,000 | $1,105,800 | 0 | $0 | 0 | $0 |
1. Zimmer Biomet Holdings, Inc. (ZMH)
2. Boston Scientific Corp (BSX)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2007-02-09 | ZMH | Sale | 106,825 | 83.92 | 8,964,754 |
2007-02-12 | ZMH | Option Ex | 106,825 | 30.19 | 3,225,046 |
2007-02-12 | ZMH | Sale | 106,825 | 83.18 | 8,885,703 |
2007-02-09 | ZMH | Option Ex | 106,825 | 30.19 | 3,225,046 |
2007-02-08 | ZMH | Sale | 71,250 | 85.28 | 6,076,200 |
2007-02-07 | ZMH | Option Ex | 75,718 | 28.67 | 2,170,532 |
2007-02-08 | ZMH | Option Ex | 71,250 | 30.19 | 2,151,037 |
2007-02-07 | ZMH | Sale | 75,718 | 84.55 | 6,401,956 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2011-12-31 | BSX | Option Ex | 333,333 | .00 | 0 |
2010-12-31 | BSX | Option Ex | 500,000 | .00 | 0 |
2009-08-11 | BSX | Buy | 100,000 | 11.06 | 1,105,800 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Elliott John Raymond (Chairman, Pres. & CE of Boston Scientific Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.